(Q46722973)

24 December 2017

title

Retinamide-induced apoptosis in glioblastomas is associated with down-regulation of Bcl-xL and Bcl-2 proteins (English)

1 reference

24 December 2017

author name string

Richard A Lytle

1

1 reference

24 December 2017

Zhihong Jiang

2

1 reference

24 December 2017

Xiao Zheng

3

1 reference

24 December 2017

Ryuji Higashikubo

4

1 reference

24 December 2017

Keith M Rich

5

1 reference

24 December 2017

publication date

1 September 2005

1 reference

24 December 2017

Journal of Neuro-Oncology

published in

1 reference

24 December 2017

volume

74

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

225-232

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1007/s11060-005-7305-z

exact match

0 references

cites work

A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients

1 reference

12 December 2020

Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study.

1 reference

12 December 2020

Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity.

1 reference

12 December 2020

Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance.

1 reference

12 December 2020

Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemoprevention

1 reference

12 December 2020

Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.

1 reference

12 December 2020

Expression of apoptosis and its related protein in astrocytic tumors

1 reference

12 December 2020

Fenretinide activates caspases and induces apoptosis in gliomas

1 reference

12 December 2020

Analysis of 2 antiapoptotic factors in gliomas: bcl-2 overexpression and p53 mutations.

1 reference

12 December 2020

All-trans-retinoic acid: a phase II Radiation Therapy Oncology Group study (RTOG 91-13) in patients with recurrent malignant astrocytoma

1 reference

12 December 2020

The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin).

1 reference

12 December 2020

N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid

1 reference

12 December 2020

Down-regulation of Bcl-2 and Bcl-xL expression with bispecific antisense treatment in glioblastoma cell lines induce cell death.

1 reference

12 December 2020

Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation

1 reference

12 December 2020

Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study

1 reference

12 December 2020

Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines

1 reference

12 December 2020

Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression

1 reference

12 December 2020

Retinoids in chemoprevention and differentiation therapy

1 reference

12 December 2020

Effect of 4-hydroxyphenylretinamide and retinoic acid on proliferation and cell cycle of cultured human breast cancer cells

1 reference

12 December 2020

Involvement of the bcl-2 gene in human follicular lymphoma

1 reference

12 December 2020

Suppression of Bcl-xL deamidation in human hepatocellular carcinomas

1 reference

12 December 2020

Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma: a North American Brain Tumor Consortium study

1 reference

12 December 2020

An informatics approach identifying markers of chemosensitivity in human cancer cell lines.

1 reference

12 December 2020

Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis

1 reference

12 December 2020

The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family

1 reference

12 December 2020

Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage

1 reference

12 December 2020

Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases

1 reference

12 December 2020

Bcl-2: prevention of apoptosis as a mechanism of drug resistance.

1 reference

12 December 2020

Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases

1 reference

12 December 2020

Recent advances in the use of vitamin A (retinoids) in the prevention and treatment of cancer

1 reference

12 December 2020

Retinoids in cancer chemoprevention. Clinical trials with the synthetic analogue fenretinide

1 reference

12 December 2020

A novel bispecific antisense oligonucleotide inhibiting both bcl-2 and bcl-xL expression efficiently induces apoptosis in tumor cells.

1 reference

12 December 2020

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

1 reference

12 December 2020

p53-Independent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide

1 reference

12 December 2020

10.1007/S11060-005-7305-Z

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

16187019

1 reference

24 December 2017